Cancer

Response to treatment in cancer cells: The abundance of the EGFR (top row) and HER2 (bottom row) receptors is reduced when the cells are exposed to triple therapy – Tagrisso, Erbitux and Herceptin (right column) and to the two antibodies, Erbitux and Herceptin (second from right column), but not when they are exposed to Tagrisso alone (second column from left) or to no therapy at all (left column)

Combined Approach Offers Hope to Lung Cancer Patients Who Become Resistant to Drugs

25.07.2018

Cancer, Disease, Drugs & Diagnostics, Diagnostic Techniques and Drugs

Three drugs together block growth from without and within

aging

A Genetic Test for Aging

10.07.2018

Cancer, Personalized Medicine, Stem Cells

How do the mutations that accumulate in our blood cells affect our health in later years?

Der Körper weiß es am besten: Ein natürlicher Heilmechanismus für entzündliche Darmerkrankungen

Der Körper weiß es am besten: Ein natürlicher Heilmechanismus für entzündliche Darmerkrankungen

30.05.2018

Die Behandlung entzündlicher Darmerkrankungen ist extrem schwierig: Gene, Darmmikroben und gestörte Immunfunktionen tragen alle dazu bei.

Cross-section of the inner lining of a human gut adjacent to a cancerous tumor

Body Knows Best: A Natural Healing Mechanism for Inflammatory Bowel Disease

30.05.2018

Biochemistry, Cancer, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics

The findings suggest that boosting signals in certain cells and not in others might even help treat colon cancer

Tethered cancer cells

Cancer Cells Seen Traveling in Tethered Groups

10.05.2018

Cancer, Systems Biology, Molecular and Cell Biology

This finding may help solve the puzzle of certain types of aggressive metastasis

Rejection and lack of rejection

Immune Tolerance May Open New Horizons for Bone Marrow and Organ Transplants

05.02.2018

Cancer, Personalized Medicine, Nutrition, Stem Cells, Systems Biology, Viruses & Microorganisms, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics

An anticancer drug keeps recipient T cells from attacking donor cells

(l-r) Dr. Ruth Scherz-Shouval, Prof. Drew Pardoll and Dr. Rony Dahan

Visits: An Interview with Prof. Drew Pardoll

30.01.2018

Cancer, Immunology

Prof. Pardoll was the keynote speaker at the recent Cancer Immunotherapy symposium sponsored by the Moross Integrated Cancer Center

Dr. Itay Tirosh, Molecular Cell Biology

Comprehending Cancer Ecosystems – One Cell at a Time

15.01.2018

Cancer, Stem Cells, Systems Biology, Molecular and Cell Biology, Disease, Drugs & Diagnostics

Dr. Itay Tirosh is finding the tumor cells that are most likely to turn malignant

Bacteria in cancer cells

How Bacteria Hinder Chemotherapy

20.09.2017

Cancer, Personalized Medicine, Systems Biology, Viruses & Microorganisms, Molecular and Cell Biology, Disease, Drugs & Diagnostics

Scientists find bacteria in pancreatic tumors that metabolize a common drug

Cancerous tumor tissue under a microscope:

Altitude Training for Cancer-Fighting Cells

18.09.2017

Cancer, Molecular and Cell Biology, Immunology

Oxygen starvation could toughen up immune T cells for cancer immunotherapy

Pages

Top Stories

Ben Kelmer Studio

New Eyes on the Sky

Dr. Gili Rosenberg

Dr. Gili Rosenberg

Prof. Daniel Zajfman

Prof. Daniel Zajfman

Prof. Michal Schwartz

Israel Prize in Life Sciences to Prof. Michal Schwartz

Press Releases

Treating a Heart Attack before It Happens

The Weight of Responsibility: Biomass of Livestock Dwarfs That of Wild Mammals

The Quantum Twisting Microscope: A New Lens on Quantum Materials